Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran

International Journal of Drug Policy

Volumn 21, Issue 6, 2010, Pages 493-500

  Zamani, Saman ^a   Radfar, Ramin ^b   Nematollahi, Pardis ^c   Fadaie, Reza ^c   Meshkati, Marjan ^c   Mortazavi, Shahrzad ^a   Sedaghat, Abbas ^d   Ono Kihara, Masako ^a   Kihara, Masahiro ^a  

^a KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^b Health and Culture Institute   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Blood borne infection; IDUs; Iran; Peer driven sampling

Indexed keywords

BUPRENORPHINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HARM REDUCTION; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PEER GROUP; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SCREENING TEST; SEXUAL BEHAVIOR; SYRINGE;

ADULT; BUPRENORPHINE; DATA COLLECTION; FEMALE; HARM REDUCTION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; MALE; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PREVALENCE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 78649322749     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.04.006     Document Type: Article

References (28)

1. Abdul-Quader A.S., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Sabin K., et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study. Journal of Urban Health 2006, 83(3):459-476.
2. Abdul-Quader A.S., Heckathorn D.D., Sabin K., Saidel T. Implementation and analysis of respondent driven sampling: Lessons learned from the field. Journal of Urban Health 2006, 83(6 Suppl.):i1-5.
3. Alizadeh A.H., Alavian S.M., Jafari K., Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan, Iran. World Journal of Gastroenterology 2005, 11(26):4085-4089.
4. Ataei B., Kassaian N., Tayeri K., Farajzadegan Z. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan-Iran: Seroprevalence and associated factors. European Journal of Internal Medicine 2009, 20:S218.
5. Azizi F., Jahed A., Hedayati M., Lankarani M., Bejestani H.S., Esfahanian F., et al. Outbreak of exogenous Cushing's syndrome due to unlicensed medications. Clinical Endocrinology (Oxford) 2008, 69(6):921-925.
6. Center for Communicable Diseases Control Iran Integrated bio-behavioral surveillance for HIV infection among injecting drug users in Iran (unpublished report) 2008, Ministry of Health and Medical Education, Tehran, Iran.
7. DeJong J., Mahfoud Z., Khoury D., Barbir F., Afifi R.A. Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: Illustrations from Lebanon. American Journal of Public Health 2009, 99(9):1562-1567.
8. Frost S.D., Brouwer K.C., Firestone Cruz M.A., Ramos R., Ramos M.E., Lozada R.M., et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health 2006, 83(6 Suppl.):i83-i97.
9. Hajiani E., Masjedizadeh R., Hashemi J., Azmi M., Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World Journal of Gastroenterology 2006, 12(43):7025-7028.
10. Imani R., Karimi A., Rouzbahani R., Rouzbahani A. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Eastern Mediterranean Health Journal 2008, 14(5):1136-1141.
11. Johnston L.G., Khanam R., Reza M., Khan S.I., Banu S., Alam M.S., et al. The effectiveness of respondent driven sampling for recruiting males who have sex with males in Dhaka, Bangladesh. AIDS and Behavior 2008, 12(2):294-304.
12. Johnston L.G., Malekinejad M., Kendall C., Iuppa I.M., Rutherford G.W. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: Field experiences in international settings. AIDS and Behavior 2008, 12(4 Suppl.):S131-141.
13. Johnston L.G., Sabin K., Mai T.H., Pham T.H. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: Reaching the unseen sex worker. Journal of Urban Health 2006, 83(6 Suppl.):i16-i28.
14. Latkin C.A., Vlahov D., Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993, 88(4):517-526.
15. Magnani R., Sabin K., Saidel T., Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005, 19(Suppl. 2):S67-S72.
16. Malekinejad M., Johnston L.G., Kendall C., Kerr L.R., Rifkin M.R., Rutherford G.W. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior 2008, 12(4 Suppl.):S105-S130.
17. Radfar, Nematollahi P., Tayeri K. Study on prevalence of HIV, HCV and HBV among IDU clients in IRANDOOST residential center, Isfahan. Paper presented at the first national congress of infection in addicts 2007.
18. Radfar R., Pooya A., Meshkaty M., Fadai R., Soltanolkotaby M.A. Pattern of behaviors and risks among injecting drug users coming in HAFTOON drop in center, Isfahan, Iran. Paper presented at the international conference on the reduction of drug related harm 2007.
19. Radfar S.R., Sadeghy S., Meshkaty M., Fadai R. An experience review: Study on ice breaking process among IDUs community in haftoon drop-in center (Isfahan, Iran). Paper presented at the international conference of drug related harm 2007.
20. Rahimi-Movaghar A., Razaghi E.M., Sahimi-Izadian E., Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Diseases 2009.
21. Scott G. They got their program, and I got mine": A cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. International Journal of Drug Policy 2008, 19(1):42-51.
22. Semaan S., Santibanez S., Garfein R.S., Heckathorn D.D., Des Jarlais D.C. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. International Journal of Drug Policy 2009, 20(1):14-27.
23. Shrestha S., Smith M.W., Broman K.W., Farzadegan H., Vlahov D., Strathdee S.A. Multiperson use of syringes among injection drug users in a needle exchange program: A gene-based molecular epidemiologic analysis. Journal of Acquired Immune Deficiency Syndromes 2006, 43(3):335-343.
24. Stormer A., Tun W., Guli L., Harxhi A., Bodanovskaia Z., Yakovleva A., et al. An analysis of respondent driven sampling with Injection Drug Users (IDU) in Albania and the Russian Federation. Journal of Urban Health 2006, 83(6 Suppl.):i73-i82.
25. Tayeri K., Kasaee N., Fadaei Nobar R., Ataei B. Prevalence of HBV and HCV among HIV+ Drug Users in Isfahan, Iran. Journal of Isfahan University of Medical Sciences 2009, 26:273-278.
26. Wattana W., van Griensven F., Rhucharoenpornpanich O., Manopaiboon C., Thienkrua W., Bannatham R., et al. Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug and Alcohol Dependence 2007, 90(2-3):228-233.
27. Yeka W., Maibani-Michie G., Prybylski D., Colby D. Application of respondent driven sampling to collect baseline data on FSWs and MSM for HIV risk reduction interventions in two urban centres in Papua New Guinea. Journal of Urban Health 2006, 83(6 Suppl.):i60-i72.
28. Zamani S., Ichikawa S., Nassirimanesh B., Vazirian M., Ichikawa K., Gouya M.M., et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy 2007, 18(5):359-363.